Start: October 16, 2019
End: February 28, 2024
Enrollment: 700
Anticholinergics are a class of drugs used to treat many medical problems and have been associated with a higher risk of dementia. This study will test the effectiveness of an application called Brain Safe to reduce older adults' exposure to prescription anticholinergics and improve function and quality of life. Participants will be randomly assigned to use either the Brain Safe application or a medication list application for one year. The applications will be loaded on a smartphone provided by the study or the participant. Brain Safe provides conversation starters for older adults to talk with their doctor about any use of anticholinergics and potential for changing or stopping the prescription. It also includes a medication list, risk calculator, and educational content.
Minimum Age: 60 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Indiana | |
---|---|
IU Health
Indianapolis, IN 46202
Recruiting
Jose Azar, MD |
|
Richard John Holden
Indianapolis, IN 46202
Recruiting
Richard J Holden, PhD |
Lead: Indiana University
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT04121858